Skip to main content
News

Baltimore’s KaloCyte Partners on $46M DARPA Program to Develop Synthetic Blood Product · BioBuzz

By February 13, 2023No Comments
Baltimores KaloCyte Partners on 46M DARPA Program to Develop Synthetic Blood Product BioBuzz

Baltimores KaloCyte Partners on 46M DARPA Program to Develop Synthetic Blood Product BioBuzzKaloCyte’s experimental synthetic red blood cell product ErythroMer could provide a solution to the high need for treating trauma in both military and civilian settings. The company was tapped to participate in a federally-funded program to develop a synthetic blood substitute.

Image: https://biobuzz.io/

{iframe}https://biobuzz.io/baltimores-kalocyte-partners-on-46m-darpa-program-to-develop-synthetic-blood-product/{/iframe}

Leave a Reply

You have successfully subscribed to the newsletter

There was an error while trying to send your request. Please try again.

BioHealth Innovation will use the information you provide on this form to be in touch with you and to provide updates and marketing.